RxDoctor Payments Data

Louis Fehrenbacher

Hematology & Oncology · Vallejo, CANPI 1942388764

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $8,740 of the $8,740 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Pfizer.

$8,740in general payments, 2019–2025

Across 4 payments — averaging $2185.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$9K
$488,898in research payments, 2019–2025

Across 48 payments — averaging $10,185 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$421K
  • Medivation LLC.$27K
  • Novartis$24K
  • Merck$7K
  • E.r. Squibb & Sons, L.L.C.$6K
  • F. Hoffmann-la Roche AG$2K
  • plus $1K from 1 others

What the payments were for

  • Speaking & faculty fees$8,740100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer4$8,740

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,740 in reported general payments places this provider in the 65th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California →

Other hematology & oncology in Vallejo

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →